Get started
Author

Florence Brellier

Observed names: Brellier, Florence, F Brellier, F. Brellier
Observed institutions: Novartis (Switzerland), Centre National de la Recherche Scientifique, Institut Gustave Roussy, IQVIA (United Kingdom), Bristol-Myers Squibb (United Kingdom), Novartis Foundation, Friedrich Miescher Institute
ORCID: 0000-0002-0143-472X
Observed ORCID: 0000-0002-0143-472X
OpenAlex ID: A5002676565
Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell Behavior
2007 · Martin Degen, Florence Brellier, et al. · Cancer Research · 85
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors
2011 · Florence Brellier, Sabrina Ruggiero, et al. · Matrix Biology · 75
Tenascin‐W is a specific marker of glioma‐associated blood vessels and stimulates angiogenesis in vitro
2009 · Enrico Martina, Martin Degen, et al. · The FASEB Journal · 71
PDF
Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients
2008 · Martin Degen, Florence Brellier, et al. · International Journal of Cancer · 57
PDF
Genetic Correction of DNA Repair-Deficient/Cancer-Prone Xeroderma Pigmentosum Group C Keratinocytes
2003 · Catherine Arnaudeau-Bégard, Florence Brellier, et al. · Human Gene Therapy · 57
ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis
2010 · Nathaniel T. Leachman, Florence Brellier, et al. · Development Growth & Differentiation · 52
Tenascins and their implications in diseases and tissue mechanics
2009 · F. Brellier, R. P. Tucker, et al. · Scandinavian Journal of Medicine and Science in Sports · 48
Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
2012 · Florence Brellier, Enrico Martina, et al. · BMC Clinical Pathology · 45
PDF
How do tenascins influence the birth and life of a malignant cell?
2011 · Florence Brellier, Ruth Chiquet‐Ehrismann · Journal of Cellular and Molecular Medicine · 45
PDF
Specific processing of tenascin-C by the metalloprotease meprinβ neutralizes its inhibition of cell spreading
2009 · Daniel Ambort, Florence Brellier, et al. · Matrix Biology · 40
Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development
2007 · Catherine Vaillant, Odyssé Michos, et al. · Development · 35
PTCH1+/− Dermal Fibroblasts Isolated from Healthy Skin of Gorlin Syndrome Patients Exhibit Features of Carcinoma Associated Fibroblasts
2009 · Alexandre Valin, Stéphanie Barnay-Verdier, et al. · PLoS ONE · 32
PDF
Tenascin-W: An extracellular matrix protein associated with osteogenesis and cancer
2010 · Enrico Martina, Ruth Chiquet-Ehrismann, et al. · The International Journal of Biochemistry & Cell Biology · 28
Tenascin-C triggers fibrin accumulation by downregulation of tissue plasminogen activator
2011 · Florence Brellier, Katrin Hostettler, et al. · FEBS Letters · 25
PDF
Ultraviolet Irradiation Represses PATCHED Gene Transcription in Human Epidermal Keratinocytes through an Activator Protein-1-Dependent Process
2004 · Florence Brellier, Claire Marionnet, et al. · Cancer Research · 24
The Adhesion Modulating Properties of Tenascin-W
2012 · Florence Brellier, Enrico Martina, et al. · International Journal of Biological Sciences · 23
PDF
Ultraviolet responses of Gorlin syndrome primary skin cells
2008 · F. Brellier, A. Valin, et al. · British Journal of Dermatology · 21
Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures
2008 · F Brellier, V Bergoglio, et al. · Oncogene · 15
Basal Cell Carcinoma in Gorlin’s Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
2015 · Yannick Gache, Florence Brellier, et al. · PLoS ONE · 11
PDF
Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study
2022 · Florence Brellier, Mar Pujades-Rodriguez, et al. · PLoS ONE · 9
PDF
Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer
2025 · Fabrice Barlesi, Adrien Dixmier, et al. · OncoImmunology · 6
Treatment Patterns, Outcomes and Healthcare Resource Utilization of Obstructive Hypertrophic Cardiomyopathy in England
2025 · Faizel Osman, Carla L. Zema, et al. · ESC Heart Failure · 4
PDF
Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study
2025 · Benoît Godbert, Elisa Gobbini, et al. · Oncology and Therapy · 3
Early Insights on Mavacamten Usage in Canada: A Retrospective Cohort Study of the Mavacamten Patient Support Program
2026 · Kevin Ong, Patrick Garceau, et al. · CJC Open · 1
PDF
Real-World Effectiveness of Mavacamten in Canada: Insights from the MAVEN Study
2026 · Adis Journals on behalf of:, Michael R. Ward, et al. · Figshare
Works count: 33
Citation count: 812
H-index: 17
I10-index: 19
Year
Topic
Type